Related Experiment Videos
Abnormal thyroid and adrenocortical function test results in intensive care patients
Annals of the Academy of Medicine, Singapore
|November 1, 1996
Summary
Thyroid and adrenal function tests can predict patient outcomes in the medical intensive care unit (MICU). Triiodothyronine and cortisol levels, combined with APACHE II scores or dopamine use, significantly improve outcome prediction accuracy.
Area of Science:
- Endocrinology
- Critical Care Medicine
Background:
- Critically ill patients often exhibit endocrine dysfunction.
- Thyroid and adrenocortical function abnormalities are common in the medical intensive care unit (MICU).
Purpose of the Study:
- To determine thyroid and adrenocortical profiles in MICU patients.
- To evaluate the utility of these profiles in predicting patient outcomes.
- To assess if endocrine markers improve existing outcome prediction scores.
Main Methods:
- Prospective cohort study of 75 consecutive MICU patients.
- Measurement of thyroid function tests (triiodothyronine, thyroxine, free thyroxine, thyrotropin) and cortisol levels.
- Comparison of endocrine profiles between survivors and non-survivors.
- Evaluation of predictive accuracy using APACHE II score and dopamine use.
Main Results:
- High prevalence of abnormal thyroid (88%) and adrenocortical (77%) function.
- Non-survivors showed lower triiodothyronine and higher cortisol levels compared to survivors (P < 0.01).
- Triiodothyronine and cortisol were independent predictors of outcome.
- Combining triiodothyronine and cortisol with APACHE II or dopamine improved predictive accuracy to 84%.
Conclusions:
- Thyroid and adrenocortical dysfunction are prevalent in MICU patients.
- Triiodothyronine and cortisol levels are significant predictors of outcome.
- Integrating endocrine markers with clinical scores enhances patient outcome prediction in the MICU.